| Period Ending | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|
|
Total Revenue
|
144,103,000
|
145,915,000
|
120,452,000
| | Cost of Revenue | 107,534,000 | 99,595,000 | 77,145,000 | | |
Gross Profit
|
36,569,000
|
46,320,000
|
43,307,000
| |
|
Operating Expenses |
|
Research Development | 1,143,000 | 1,454,000 | 989,000 |
|
Selling General and Administrative | 14,532,000 | 14,951,000 | 13,778,000 |
|
Non Recurring | 3,994,000 | 2,630,000 | 2,168,000 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
16,900,000
|
27,285,000
|
26,372,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (524,000) | (867,000) | (996,000) |
|
Earnings Before Interest And Taxes | 14,493,000 | 26,724,000 | 27,274,000 |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | 14,493,000 | 26,724,000 | 27,274,000 |
|
Income Tax Expense | 3,562,000 | 6,732,000 | 6,825,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 10,974,000 | 20,222,000 | 20,796,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
10,931,000
|
19,992,000
|
20,449,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
10,931,000
|
19,992,000
|
20,449,000
|
|
1.77%